Financials
- Market Capitalization 10.61 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
33.02
売上高対価格比率
3.64
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 847 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 471.75 USD | -1.08% | -6.58% | -12.64% | +11.36% | 10.90 B USD | ||
| 857 | PCVX Vaxcyte, Inc. - Common Stock | 71.38 USD | +9.78% | -18.15% | +18.89% | +68.75% | 10.62 B USD | ||
| 890 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 79.78 USD | +1.31% | +5.02% | +2.43% | +101.24% | 10.15 B USD | ||
| 907 | KRYS Krystal Biotech, Inc. - Common Stock | 331.61 USD | +1.32% | +2.42% | -5.46% | +77.21% | 9.82 B USD |